Velcheti, V., Hu, X., Piperdi, B., & Burke, T. (2021). Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices. Nature Portfolio.
Style de citation Chicago (17e éd.)Velcheti, Vamsidhar, Xiaohan Hu, Bilal Piperdi, et Thomas Burke. Real-world Outcomes of First-line Pembrolizumab Plus Pemetrexed-carboplatin for Metastatic Nonsquamous NSCLC at US Oncology Practices. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Velcheti, Vamsidhar, et al. Real-world Outcomes of First-line Pembrolizumab Plus Pemetrexed-carboplatin for Metastatic Nonsquamous NSCLC at US Oncology Practices. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.